cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with Disease, Pulmonary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ratjen, F | 1 |
1 review(s) available for cystic fibrosis transmembrane conductance regulator (505-511) and Disease, Pulmonary
Article | Year |
---|---|
New pulmonary therapies for cystic fibrosis.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Diseases; Peptide Fragments; Sodium Channel Blockers; Treatment Outcome | 2007 |